Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance-Reference-Cited by-同舟云学术

Synergistic combination chemotherapy using carrier-free celastrol and doxorubicin nanocrystals for overcoming drug resistance

Published:2018 Issue:26 Volume:10 Page:12639-12649
ISSN:2040-3364
Container-title:Nanoscale
language:en
Short-container-title:Nanoscale

Author:

Xiao Yating¹²³⁴⁵,Liu Jing¹²³⁴⁵,Guo Mengyu¹²³⁴⁵,Zhou Huige¹²³⁴⁵,Jin Jun¹²³⁴⁵,Liu Jiaming¹²³⁴⁵,Liu Ying¹²³⁴⁵,Zhang Zhanjun⁶³⁷⁵,Chen Chunying¹²³⁴⁵^ORCID

Affiliation:

1. CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellent in Nanoscience

2. National Center for Nanoscience and Technology of China

3. University of Chinese Academy of Sciences

4. Beijing 100190

5. China

6. School of Chemical Sciences

7. Beijing 100049

Abstract

Celastrol and doxorubicin are self-assembled into carrier-free and biocompatible nanoparticles via a green method, which enhance synergistic combination chemotherapy and overcome drug resistance.

Funder

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science

Link

http://pubs.rsc.org/en/content/articlepdf/2018/NR/C8NR02700E

Reference42 articles.

1. P-glycoprotein: from genomics to mechanism

2. pH-Sensitive nano-systems for drug delivery in cancer therapy

3. Nanoparticle Assembly of Surface-Modified Proteins

4. Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery

5. Co-delivery of doxorubicin and quercetin via mPEG–PLGA copolymer assembly for synergistic anti-tumor efficacy and reducing cardio-toxicity

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Copper coordinated nano-assemblies based on photosensitizer and chemo-prodrugs for cascade-activated and enhanced apoptosis-cuproptosis;Colloids and Surfaces A: Physicochemical and Engineering Aspects;2024-11

2. Capecitabine mitigates cardiac allograft rejection via inhibition of TYMS-Mediated Th1 differentiation in mice;International Immunopharmacology;2024-11

3. Celastrol Derivative/DOX Co-Assembled Nanodrug for Enhanced Antitumor Therapy;Current Drug Delivery;2024-08-26

4. Progress of proteolysis-targeting chimeras (PROTACs) delivery system in tumor treatment;International Journal of Biological Macromolecules;2024-08

5. Redox-responsive hyaluronic acid-celastrol prodrug micelles with glycyrrhetinic acid co-delivery for tumor combination therapy;Chinese Chemical Letters;2024-07